Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice

Journal of General Virology

Volumn 85, Issue 8, 2004, Pages 2479-2483

  Kocisko, David A ^a   Morrey, John D ^b   Race, Richard E ^a   Chen, Jiancao ^c   Caughey, Byron ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UTAH STATE UNIVERSITY   (United States)

^c Hydraulic Science Research Institute of Sichuan Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; GRAPE SEED EXTRACT; PINE BARK EXTRACT; PLANT EXTRACT; PRION PROTEIN; PRION PROTEIN INHIBITOR; PROTEIN INHIBITOR; TANNIN; TETRANDRINE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG PENETRATION; DRUG TISSUE LEVEL; IN VIVO STUDY; INCUBATION TIME; INFECTION PREVENTION; INOCULATION; MOUSE; NONHUMAN; PINE; PRIORITY JOURNAL; SCRAPIE; TEA; TRANSGENIC MOUSE; ANIMAL; DRUG ANTAGONISM;

MUS MUSCULUS; RODENTIA; VITIS SP.;

ANIMALS; CELLS, CULTURED; HYDROLYZABLE TANNINS; MICE; MICE, TRANSGENIC; PRPSC PROTEINS; SCRAPIE;

EID: 4043098362     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80082-0     Document Type: Article

References (28)

1. Aguzzi, A., Glatzel, M., Montrasio, F., Prinz, M. & Heppner, F. L. (2001). Interventional strategies against prion diseases. Nat Rev Neurosci 2, 745-749.
2. Barret, A., Tagliavini, F., Forloni, G. & 13 other authors (2003). Evaluation of quinacrine treatment for prion diseases. J Virol 77, 8462-8469.
3. Beranger, F., Mange, A., Solassol, J. & Lehmann, S. (2001). Cell culture models of transmissible spongiform encephalopathies. Biochem Biophys Res Commun 289, 311-316.
4. Birkett, C. R., Hennion, R. M., Bembridge, D. A., Clarke, M. C., Chree, A., Bruce, M. E. & Bostock, C. J. (2001). Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. EMBO J 20, 3351-3358.
5. Brown, P. (2002). Drug therapy in human and experimental transmissible spongiform encephalopathy. Neurology 58, 1720-1725.
6. Burke, K., Chandler, C. J., Starr, B. S. & Starr, M. S. (1990). Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse. Pharmacol Biochem Behav 36, 729-733.
7. Caughey, B. & Lansbury, P. T. (2003). Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26, 267-298.
8. Caughey, B. & Race, R. E. (1992). Potent inhibition of scrapie-associated PrP accumulation by Congo red. J Neurochem 59, 768-771.
9. Caughey, B. & Raymond, G. J. (1993). Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 67, 643-650.
10. Caughey, W. S., Raymond, L. D., Horiuchi, M. & Caughey, B. (1998). Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc Natl Acad Sci U S A 95, 12117-12122.
11. Caughey, B., Horiuchi, M., Demaimay, R. & Raymond, G. J. (1999). Assays of protease-resistant prion protein and its formation. Methods Enzymol 309, 122-133.
12. Collins, S. J., Lewis, V., Brazier, M., Hill, A. F., Fletcher, A. & Masters, C. L. (2002). Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann Neurol 52, 503-506.
13. Doh-ura, K., Iwaki, T. & Caughey, B. (2000). Lysosomotropic agents and cysteine protease inhibitors inhibit accumulation of scrapie-associated prion protein. J Virol 74, 4894-4897.
14. Dormont, D. (2003). Approaches to prophylaxis and therapy. Br Med Bull 66, 281-292.
15. Ehlers, B. & Diringer, H. (1984). Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J Gen Virol 65, 1325-1330.
16. Farquhar, C. F. & Dickinson, A. G. (1986). Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J Gen Virol 67, 463-473.
17. Gabizon, R., Meiner, Z., Halimi, M. & Bensasson, S. A. (1993). Heparin-like molecules bind difterentially to prion proteins and change their intracellular metabolic-fate. J Cell Physiol 157, 319-325.
18. Sc and delays onset of prion disease. EMBO J 20, 3957-3966.
19. Ingrosso, L., Ladogana, A. & Pocchiari, M. (1995). Congo red prolongs the incubation period in scrapie-infected hamsters. J Virol 69, 506-508.
20. Kimberlin, R. H. & Walker, C. A. (1986). Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrob Agents Chemother 30, 409-413.
21. Kobayashi, Y., Hirata, K., Tanaka, H. & Yamada, T. (2003). Quinacrine administration to a patient with creutzfeldt-Jakob disease who received a cadaveric dura mater graft - an EEG evaluation. Rinsho Shinkeigaku 43, 403-408.
22. Kocisko, D. A., Baron, G. S., Rubenstein, R., Chen, J., Kuizon, S. & Caughey, B. (2003). New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol 77, 10288-10294.
23. Korth, C., May, B. C., Cohen, F. E. & Prusiner, S. B. (2001). Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A 98, 9836-9841.
24. Nakajima, M., Yamada, T., Kusuhara, T., Furukawa, H., Takahashi, M., Yamauchi, A. & Kataoka, Y. (2004). Results of quinacrine administration to patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 17, 158-163.
25. Priola, S. A., Raines, A. & Caughey, W. S. (2000). Porphyrin and phthalocyanine anti-scrapie compounds. Science 287, 1503-1506.
26. Race, R. E., Caughey, B., Graham, K., Ernst, D. & Chesebro, B. (1988). Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol 62, 2845-2849.
27. Race, R., Oldstone, M. & Chesebro, B. (2000). Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. J Virol 74, 828-833.
28. Schonberger, O., Horonchilk, L., Gabizon, R., Papy-Garcia, D., Barritault, D. & Taraboulos, A. (2003). Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis. Biochem Biophys Res Commun 312, 473-479.